Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe study record now reflects December 2025 update dates (2025-12-08 and 2025-12-05). Earlier November dates (2025-11-20 and 2025-11-19) have been removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section wording was updated to clarify PubMed sourcing, with a new revision date added. No changes were made to the study design, eligibility criteria, or results.SummaryDifference0.3%

- Check28 days agoChange DetectedDeleted the government funding lapse notice warning that information may be out of date and transactions may not be processed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo additions or deletions are evident in the page; the study record appears unchanged across sections such as Overview, Eligibility Criteria, Design, and Contacts.SummaryDifference0.4%

- Check71 days agoChange DetectedCore content status message updated and software version bumped to v3.2.0 with new dates; older dated entries and v3.1.0 removed.SummaryDifference2%

- Check78 days agoChange DetectedUpdated contact info and version (v3.1.0) while removing an older resource entry and older version (v3.0.2).SummaryDifference0.2%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.